SCHEMBL25753506

SCHEMBL25753506

CC(C)(C)NC(=O)c1ccc2c[nH]nc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.50
POLB P06746 1/20 0.50
PRKAA1 Q13131 2/20 0.48
PLK4 O00444 1/20 0.48
CHEK1 O14757 1/20 0.48
AURKA O14965 1/20 0.48
DAPK3 O43293 1/20 0.48
CHEK2 O96017 1/20 0.48
CDK1 P06493 1/20 0.48
PIM1 P11309 1/20 0.48
RPS6KB1 P23443 1/20 0.48
FLT4 P35916 1/20 0.48
KDR P35968 1/20 0.48
MAPK9 P45984 1/20 0.48
CSNK1D P48730 1/20 0.48
GSK3A P49840 1/20 0.48
GSK3B P49841 1/20 0.48
JAK3 P52333 1/20 0.48
CSNK2A1 P68400 1/20 0.48
DYRK1A Q13627 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9989122 0.83 PLK1 (0.48) CHEK2HPGDSSMN1; SMN2
SCHEMBL25402169 0.81 HDAC6 (0.46)
SCHEMBL27061741 0.81 TP53 (0.47) MAPTPOLBHPGDSRIPK1NPC1
SCHEMBL21730148 0.78 KDM4E (0.50) MAPTDYRK1ALMNAKMT2AALDH1A1
SCHEMBL25401469 0.76 TDP1 (0.53) MAPTPOLBKMT2ANPC1ALDH1A1
SCHEMBL17112019 0.75 RAB9A (0.56) MAPTPOLBJAK2LMNAKMT2A
SCHEMBL25753501 0.75 NPC1 (0.66) MAPTPOLBLMNAKMT2ANPC1
SCHEMBL27062550 0.74 ALDH1A1 (0.34) MAPTLMNANPC1ALDH1A1RAB9A
Hydrochloric Acid SCHEMBL31386777 0.73 LCK (0.44) CHEK2JAK3HPGDSJAK2KMT2A
SCHEMBL9989116 0.72 NPC1 (0.60) KDRHPGDSLMNANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240026358-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2024-01-25 US disclosed
US-20230203484-A1 DOUBLE STRANDED OLIGONUCLEOTIDE COMPOSITIONS AND METHODS RELATING THERETO WAVE LIFE SCIENCES LTD. (SG) 2023-06-29 US disclosed
US-20230203087-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2023-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203087-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF RNGTT, NSUN2, ALKBH1 MAPT 4649/4885POLB 190/4885PRKAA1 2036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.